Related Experiment Video
Updated: Jan 23, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Statin Effects on Incidence, Treatment Success, and Mortality of Clostridium difficile Infections
Marian L Gaviola1, Emily C Scribe1, Haley N Leverett1
1University of North Texas System College of Pharmacy, Fort Worth, TX, USA.
Insights
Statin use may reduce the risk of developing Clostridium difficile infection (CDI) and improve treatment outcomes. However, its impact on mortality remains uncertain, requiring further research.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Clostridium difficile infection (CDI) is a significant healthcare-associated infection.
- Statins are widely used lipid-lowering medications with potential immunomodulatory effects.
Purpose of the Study:
- To review the impact of statin use on CDI incidence, treatment success, and mortality.
- To assess the protective effects of statins in patients at risk for or diagnosed with CDI.
Main Methods:
- A comprehensive literature search was conducted up to January 2019.
- Included studies evaluated the effects of statins (HMG-CoA inhibitors) on CDI-related outcomes.
- Eight retrospective studies were identified for review.
Main Results:
- Five studies suggested statins may decrease the risk of developing CDI.
- One study indicated improved treatment response against CDI with statin use.
- Three studies examined statin use and CDI mortality, with only one finding a significant benefit.
Conclusions:
- Statin use may offer protection against CDI development and enhance treatment success.
- The benefit of statins on CDI-related mortality is currently unclear.
- Larger, prospective studies are needed to confirm findings and identify optimal patient populations.
Purpose:
To review the effects of statin use in patients at risk for or diagnosed with Clostridium difficile infection (CDI) on CDI incidence, treatment success, and mortality.
Methods:
A literature search was performed through January 2019 using the following terms: statins, HMG-CoA inhibitors, Clostridium difficile, Clostridium difficile associated diarrhea, and Clostridium difficile infection. Additional references were identified from a review of literature citations. Studies evaluating statin effects on C difficile-related outcomes were included.
Results:
A total of 8 studies were identified for inclusion in this review. All studies were retrospective. Five studies reported the association between statin use and the development of CDI, suggesting that statins may decrease risk of CDI development in patients already on statin. In one study, there was an improved treatment response against CDI with the use of statin. Three retrospective studies evaluated statin use and mortality from CDI and only one study found significant mortality benefit in statin users.
Conclusions:
Statin use may have a protective effect against the development of CDI and improve CDI treatment success; however, it is unclear if use confers a mortality benefit. Current data remain sparse and larger, prospective studies are needed to confirm current results and identify the specific population that may benefit the most from this intervention.
More Related Videos
Related Concept Videos
Ecological Succession
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects

